We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $751B
1-Year Est. Return 38.74%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+0.12%
1 Year Est. Return
+38.74%
3 Year Est. Return
+107.64%
5 Year Est. Return
+136.97%
10 Year Est. Return
+527.18%
AUM
$306B
AUM Growth
+$4.93B
Cap. Flow
+$7.83B
Cap. Flow %
2.56%
Top 10 Hldgs %
17.03%
Holding
3,610
New
202
Increased
2,185
Reduced
922
Closed
109

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$269M
2
AMZN icon
Amazon
AMZN
+$242M
3
AAPL icon
Apple
AAPL
+$215M
4
AMGN icon
Amgen
AMGN
+$212M
5
CFG icon
Citizens Financial Group
CFG
+$193M

Sector Composition

Rank Sector Weight
1 Technology 20.68%
2 Financials 13.54%
3 Healthcare 12.2%
4 Consumer Discretionary 10.79%
5 Industrials 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALCO icon
3501
Alico
ALCO
$293M
-21,245
Closed -$757K
APRE icon
3502
Aprea Therapeutics
APRE
$9.84M
-2,518
Closed -$246K
AQST icon
3503
Aquestive Therapeutics
AQST
$612M
-74,757
Closed -$297K
ASMB icon
3504
Assembly Biosciences
ASMB
$590M
-16,171
Closed -$753K
ASPS icon
3505
Altisource Portfolio Solutions
ASPS
$65.3M
-4,427
Closed -$315K
ATLO icon
3506
AMES National
ATLO
$287M
-11,198
Closed -$275K
BAB icon
3507
Invesco Taxable Municipal Bond ETF
BAB
$876M
-6,610
Closed -$219K
BABA icon
3508
Alibaba
BABA
$272B
-2,686
Closed -$609K
CALC icon
3509
CalciMedica
CALC
$13.7M
-335
Closed -$128K
CDTX
3510
DELISTED
Cidara Therapeutics
CDTX
-1,250
Closed -$51K
CMCT
3511
Creative Media & Community Trust
CMCT
$8.72M
-5
Closed -$1.01M
COCP icon
3512
Cocrystal Pharma
COCP
$22.5M
-3,270
Closed -$50K
CRD.B icon
3513
Crawford & Co Class B
CRD.B
$559M
-43,657
Closed -$376K
EEM icon
3514
iShares MSCI Emerging Markets ETF
EEM
$30.7B
-5,904
Closed -$326K
ELVN icon
3515
Enliven Therapeutics
ELVN
$3.99B
-4,571
Closed -$145K
EMLC icon
3516
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$5.08B
-3,325,263
Closed -$104M
FSTR icon
3517
Foster
FSTR
$389M
-47,561
Closed -$887K
FTK icon
3518
Flotek Industries
FTK
$954M
-6,630
Closed -$69K
GBLI icon
3519
Global Indemnity Group
GBLI
$439M
-8,941
Closed -$236K
GHM icon
3520
Graham Corp
GHM
$982M
-43,859
Closed -$604K
GNPX icon
3521
Genprex
GNPX
$2.83M
0
-$67K
GORO icon
3522
Goldgroup Mining
GORO
$484M
-8,524
Closed -$88K
GSIT icon
3523
GSI Technology
GSIT
$191M
-10,802
Closed -$61K
GYRE icon
3524
Gyre Therapeutics
GYRE
$709M
-1,748
Closed -$57K
HDSN
3525
Hudson Technologies
HDSN
$224M
-14,328
Closed -$49K

Similar funds

Charles Schwab's Q3 2021 Portfolio in Review

As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
  • Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
  • Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
  • Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
  • Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
  • Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
  • Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.

Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.